cancerhealth.com
Dec 13, 2024, 16:02
Brandon Sheffield: Canadian Expert Consensus on Predictive Biomarker Testing in Gastric and GEJ Adenocarcinoma
Brandon Sheffield, Diagnostic and Molecular Pathologist at William Osler Health System, shared on LinkedIn:
“Great new resource for pathologists and oncologists!
A lot has changed in gastric cancer, we have a lot of new therapies to offer. Pathologists are playing a big part here with Claudin18 becoming the latest IHC biomarker coming into play for precision medicine in gastric cancer patients.
Read on to see some helpful recommendations from Canadian pathologists and oncologists.”
Authors: Christine Brezden-Masley, Pierre O. Fiset, Carol C. CheungThomas Arnason, Justin Bateman, Martin Borduas, Gertruda Evaristo, Diana N. Ionescu, Howard J. Lim, Brandon S. Sheffield, Sara V. Soldera, Catherine J. Streutker
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 9, 2025, 16:14
Aug 9, 2025, 16:13
Aug 9, 2025, 15:46
Aug 9, 2025, 15:19
Aug 9, 2025, 14:56
Aug 9, 2025, 14:53
Aug 9, 2025, 14:51